Why is $RARE moving today? · SEC 8-K archive

$RARE SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $RARE: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $RARE filing catalyst

Why did $RARE trigger an AI stock catalyst alert?

$RARE triggered a Stock Catalyst AI alert on 2026-11-03 00:00:00 UTC for a SEC 8-K filing (AI Score: +3.0/10). Headline: Ultragenyx Reports Q3 Revenue of $173M, Narrows Net Loss and Announces Cost Reductions. Key points: - Total Q3 revenue rose 8.1% YoY to $173M, led by $109M in Crysvita and $30M in Dojolvi. - GAAP net loss narrowed to -$118M (-$1.16/share) vs -$180M (-$1.81/share) in prior-year period. - Implemented Item 2.05 cost reduction plan and reiterated goal of reaching profitability in 2027.

How did $RARE stock react after the SEC filing?

After the SEC 8-K for $RARE, observed market reaction: T0 price $16.63. Past moves do not guarantee future results.

Where can I get real-time $RARE SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $RARE via Telegram and the VIP Web Terminal from €10/month.

$RARE – Ultragenyx Reports Q3 Revenue of $173M, Narrows Net Loss and Announces Cost Reductions

Ultragenyx Pharmaceutical Inc.
· SEC 8-K · All $RARE

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+3.0 / 10)
  • Total Q3 revenue rose 8.1% YoY to $173M, led by $109M in Crysvita and $30M in Dojolvi.
  • GAAP net loss narrowed to -$118M (-$1.16/share) vs -$180M (-$1.81/share) in prior-year period.
  • Implemented Item 2.05 cost reduction plan and reiterated goal of reaching profitability in 2027.